Top Private Equity (PE) Firms in China
China's private equity market sits among the most structurally complex in the world, shaped by the interplay between state-linked capital, domestic growth funds, and cross-border firms operating across both RMB and USD structures. Firms here range from healthcare specialists with trans-Pacific footprints to generalist buyout platforms managing tens of billions, which means the gap between a relevant investor and an irrelevant one can be wider than in most other markets.
The directory above covers every PE firm in PEL's database for China, filterable by sector, stage, geography, and check size. Below, we go firm by firm through the most notable names on that list: what each one actually invests in, where its real focus lies, and which companies it has backed. Bring that context back to the filters above and the shortlist gets a lot easier to trust.
1. Boyu Capital
With US$40 billion in AUM as of 2022 and more than 200 portfolio companies, Boyu Capital operates at a scale that puts it in a different category from most China-focused PE firms. Founded in 2010 and headquartered in Hong Kong, the firm has raised successive large USD funds, including approximately $2.1 billion in 2016 and a target of $6 billion for its more recent fund reported in early 2021. Its investor base in Ant Group gives a sense of where the firm operates on the maturity spectrum: large, high-profile positions in companies that are already reshaping their sectors rather than early bets on unproven models.
For founders and intermediaries trying to assess relevance, Boyu's scale and portfolio breadth suggest it suits companies that have already achieved significant market position and are seeking a partner with the capital and relationships to support a major next phase.
2. Centurium Capital
Centurium has moved quickly for a firm of its age: founded in 2017, the Beijing-based firm had raised over US$4.2 billion across USD and RMB funds and reached US$6.2 billion in total AUM by December 2022, with a team of approximately 60 people. Its ranking of 10th among all China-based firms in the 2022 PEI 300 is a concrete marker of how fast it has established itself relative to firms that have been operating for much longer.
Sector focus spans consumer, business services, healthcare, and technology, which is broad enough to mean Centurium evaluates a wide range of companies but concentrated enough that purely industrial or infrastructure-oriented businesses fall outside its scope.
3. 6 Dimensions Capital
6 Dimensions Capital is built around a single sector thesis: healthcare. Founded in 2017, the firm closed its inaugural USD fund at $533 million and an RMB fund at RMB 2.06 billion, bringing total AUM above RMB 10 billion (roughly USD 1.5 billion). Its 104 investments, drawn from public deal-tracking data, reflect a fast deployment pace for a fund of that size. The Curon Biopharmaceutical Series A at $150 million in 2018 shows a willingness to lead large rounds at early clinical stages.
The firm's offices in Boston, San Francisco, Hong Kong, and Shanghai are not incidental. That footprint is the architecture of a fund that sources from global biotech hubs and moves capital into China, or brings China-originated science to Western markets. For a healthcare or biopharma company operating across those geographies, that structure matters more than AUM alone.
4. Bohai Industrial Investment Fund Management Co., Ltd.
Bohai Industrial Investment Fund Management operates as an investment arm of Bank of China, founded in 2006 with an authorized capital of RMB 20 billion. Its Tianjin base and state-linked structure place it firmly within China's government-adjacent capital ecosystem, which has shaped both its deal flow and its LP relationships. In 2013, the firm co-founded BHR Partners, a joint venture that reached CN¥12 billion in AUM by April 2017.
The state-banking lineage is relevant context for any company considering engagement. Bohai's deal decisions, timelines, and approval processes reflect that institutional character more than those of a typical independent GP.
5. CBC-Capital
CBC-Capital has built a focused TMT practice over nearly two decades, investing across technology, media, and telecom with over USD 3 billion in AUM and nine funds in its dataset since Dr. Edward Suning Tian founded the firm in 2006. The sector concentration here is more than aspirational: the firm's singular TMT focus over nearly two decades reflects sustained conviction around digital infrastructure and communications rather than a rotating thematic lens.
TMT-focused companies in China looking for a firm with long institutional memory in that space, rather than a generalist with a recent TMT allocation, will find a different kind of conversation at CBC.
6. Canyon Bridge Capital Partners, Inc.
Canyon Bridge operates out of Beijing with a Palo Alto presence, co-founded in 2016 by Ray Bingham and John Kao.. The firm raised approximately $1 billion for technology investments, with a reported $1.5 billion in backing from Chinese investors noted in 2017 coverage. Its typical check size of $10 to $50 million positions it toward growth-stage technology companies rather than either seed or large buyout.
The cross-Pacific structure is the defining feature here. Canyon Bridge was designed from inception to bridge Chinese capital with Western technology assets, which means the firm's strategic and regulatory context is more complicated than a domestically oriented peer, and also more relevant for certain cross-border technology transactions.
7. Beijing Capital Private Equity
Beijing Capital Private Equity brings one of the longer track records in this list, having operated since 1995. Investment tickets run between $1 million and $5 million with a holding horizon of 3 to 5 years, parameters that define a particular niche: earlier-stage or smaller companies where a patient but not open-ended ownership period fits the business model.
That combination of vintage and ticket size suggests a firm that has operated through multiple China market cycles, which is a different kind of institutional knowledge than a fund raised in the post-2015 environment carries.
8. Cedarlake Capital
Cedarlake Capital is built around its founder: Bao Yi, whose background spans more than 20 years in investment banking and private equity, started the firm in 2016. The firm is based in Shanghai, with offices also located in Hong Kong, and has a team of 11 to 50 people. Its AUM sits in the $1 to $5 million range per the available data, which places it at the smaller end of this group. For companies that are earlier in their trajectory and seeking a GP-level relationship with a senior operator rather than a large institutional process, Cedarlake represents a structurally different engagement model than the multi-billion AUM names on this page.
For a company sized appropriately for a $1 to $5 million check, Beijing Capital's three-decade operating history is a real advantage: few PE firms in this directory have underwritten multiple China market cycles at this ticket size.
Let's Recap
The firms here are not a single peer group, so match them to what you actually need. Boyu Capital and Centurium run at institutional scale, with broad mandates and the muscle for large, complex deals.
6 Dimensions and CBC-Capital go the other way, deep specialists in healthcare and TMT respectively, more focused than their AUM suggests. Bohai brings state-banking capital and institutional weight, while Canyon Bridge is built for cross-border technology deals between China and the US rather than purely domestic ones. At the smaller end, Beijing Capital Private Equity and Cedarlake Capital write $1 to $5 million cheques with direct, senior-partner relationships and longer holds, a different posture toward founders than a multi-fund platform.
Who to approach, by need:
- Large-scale growth or late-stage, strong market position: Boyu Capital
- Consumer, business services, healthcare, or tech growth at platform scale: Centurium Capital
- Healthcare or biopharma with cross-border US-China ambitions: 6 Dimensions Capital
- Comfortable with, or seeking, state-affiliated capital: Bohai Industrial Investment Fund Management
- TMT companies wanting a two-decade sector specialist: CBC-Capital
- Growth-stage cross-border technology: Canyon Bridge Capital Partners
- Smaller or earlier-stage, $1 to $5 million cheque, longer hold: Beijing Capital Private Equity
- Earlier-stage, wanting a direct GP-level relationship over an institutional process: Cedarlake Capital
The fastest way to act on this is Private Equity List's API and MCP tools: pull the firms matching your sector, stage, and cheque size straight into your spreadsheet or CRM, or connect the live database to an AI assistant like Claude and have it shortlist and confirm current fund status for you before you reach out.